An evaluation of morphological and functional multi-parametric MRI sequences in classifying non-muscle and muscle invasive bladder cancer
暂无分享,去创建一个
Carlo Catalano | Valeria Panebianco | Maurizio Del Monte | Ettore De Berardinis | C. Catalano | M. Gallucci | J. Catto | V. Panebianco | Marcello Domenico Grompone | Giuseppe Simone | Michele Gallucci | James Catto | Giovanni Barchetti | Constantino Leonardo | Davide Carano | G. Simone | G. Barchetti | D. Carano | E. D. Berardinis | C. Leonardo | M. Monte | E. Berardinis
[1] D. Collins,et al. Dynamic MRI for imaging tumor microvasculature: Comparison of susceptibility and relaxivity techniques in pelvic tumors , 2007, Journal of magnetic resonance imaging : JMRI.
[2] C. la Vecchia,et al. The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-analysis of Incidence and Mortality Risks. , 2016, European urology.
[3] M. Abbod,et al. Disease specific mortality in patients with low risk bladder cancer and the impact of cystoscopic surveillance. , 2013, The Journal of urology.
[4] Y. Lotan,et al. The economics of bladder cancer: costs and considerations of caring for this disease. , 2014, European urology.
[5] M. Bulut,et al. The value of diffusion-weighted MRI in the diagnosis of malignant and benign urinary bladder lesions. , 2011, The British journal of radiology.
[6] J. Catto,et al. Comparative outcomes of primary, recurrent, and progressive high-risk non-muscle-invasive bladder cancer. , 2013, European urology.
[7] A. Laupacis,et al. Longer wait times increase overall mortality in patients with bladder cancer. , 2009, The Journal of urology.
[8] M. Schostak,et al. Hematogenous Tumor Cell Spread Following Standard Transurethral Resection of Bladder Carcinoma. , 2016, European urology.
[9] Jian Guan,et al. Multiparametric 3-T MRI for differentiating low-versus high-grade and category T1 versus T2 bladder urothelial carcinoma. , 2015, AJR. American journal of roentgenology.
[10] M. Babjuk,et al. Reply to Harry Herr's Letter to the Editor re: Marko Babjuk, Andreas Böhle, Maximilian Burger, et al. EAU Guidelines on Non-muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol 2017;71:447-61. , 2017, European urology.
[11] Yan Guo,et al. Comparison of Early Submucosal Enhancement and Tumor Stalk in Staging Bladder Urothelial Carcinoma. , 2016, AJR. American journal of roentgenology.
[12] Laurence Collette,et al. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. , 2002, European urology.
[13] A. Aprikian,et al. Delay in the surgical treatment of bladder cancer and survival: systematic review of the literature. , 2006, European urology.
[14] Tarek El-Diasty,et al. Bladder cancer: diagnosis with diffusion-weighted MR imaging in patients with gross hematuria. , 2009, Radiology.
[15] A. Jemal,et al. International variations in bladder cancer incidence and mortality. , 2014, European urology.
[16] Maximilian Burger,et al. EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. , 2017, European urology.
[17] Jurgen J Fütterer,et al. Multiparametric MRI of the bladder: ready for clinical routine? , 2014, AJR. American journal of roentgenology.
[18] A. Cox,et al. Contemporary Occupational Carcinogen Exposure and Bladder Cancer: A Systematic Review and Meta-analysis. , 2015, JAMA oncology.
[19] Carlo Catalano,et al. In vivo 3D neuroanatomical evaluation of periprostatic nerve plexus with 3T-MR Diffusion Tensor Imaging. , 2013, European journal of radiology.
[20] J. Kawamura,et al. A new staging criterion for bladder carcinoma using gadolinium‐enhanced magnetic resonance imaging with an endorectal surface coil: a comparison with ultrasonography , 2000, BJU international.
[21] Adilson Prando,et al. Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade , 2009 .
[22] J. Gschwend,et al. An updated critical analysis of the treatment strategy for newly diagnosed high-grade T1 (previously T1G3) bladder cancer. , 2010, European urology.
[23] P. Carroll,et al. Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging. , 1994, Radiology.
[24] G J M Parker,et al. Comparison of dynamic contrast‐enhanced MRI and dynamic contrast‐enhanced CT biomarkers in bladder cancer , 2011, Magnetic resonance in medicine.
[25] D. Bluemke,et al. Dynamic MRI of bladder cancer: evaluation of staging accuracy. , 2005, AJR. American journal of roentgenology.